Lexology January 23, 2025
Among the many rescissions of Biden administration Executive Orders, signed by President Trump on his administration’s first day, was a rescission of an Executive Order that encouraged Medicare to lower drug costs and makes other changes. The Center for Medicare and Medicaid Innovation (CMMI) at the Center for Medicare and Medicaid Services (CMS) had announced three models in February 2023.
One model would have encouraged Medicare drug plans to offer a copayment for certain inexpensive generic drugs capped at $2/month/drug. Another would have called on state Medicaid agencies to jointly create outcome-based agreements with manufacturers for expensive cell and gene therapies and that model was intended to ensure that states pay a price based on the drug having its desired...
Today's Sponsors
Today's Sponsor